{
    "root": "35570537-f855-4577-8a82-de357f115307",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "RYONCIL",
    "value": "20250311",
    "ingredients": [],
    "indications": {
        "text": "ryoncil indicated treatment steroid refractory acute graft versus host disease ( sr-agvhd ) pediatric patients 2 months age older .",
        "doid_entities": [
            {
                "text": "graft versus host disease (DOID:0081267)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0081267"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "acute graft versus",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_99920"
            }
        ]
    },
    "contraindications": {
        "text": "intravenous .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "ryoncil supplied sterile , cryopreserved cell suspension ex-vivo culture-expanded allogeneic bone marrow-derived mesenchymal stromal cells ( msc ) vials . ryoncil provided customized kit meet dosing requirements single dose patient [ ( 2.1 ) ] , kit containing : cartons containing sufficient ryoncil one infusion based patient weight ( table 5 ) sufficient alcohol wipes preparation ryoncil infusions . kit sizes national codes ( ndc ) provided table 5. table 5 : ryoncil kit sizes patient weight ( kg ) kit contents ( single infusion ) number kits needed : 4-vial cartons 1-vial cartons total cartons number alcohol wipes ndc number initial course 2nd course relapse cr < 12.5 0 1 1 1 73648-111-01 8 4 8 12.5- < 25 0 2 2 2 73648-112-02 25- < 37.5 0 3 3 3 73648-113-03 37.5- < 50 1 0 1 4 73648-114-01 50- < 62.5 1 1 2 5 73648-115-02 62.5- < 75 1 2 3 6 73648-116-03 75- < 87.5 1 3 4 7 73648-117-04 87.5- < 100 2 0 2 8 73648-118-02 ryoncil shipped facility liquid nitrogen dry shipper maintained temperature \u2264 -135\u00b0c . storage conditions : ryoncil must remain frozen \u2264 -135\u00b0c liquid nitrogen vapor phase thawed immediately prior . handling : restrict preparation ryoncil medical facility medical personnel trained aseptic technique . disposal : dispose empty partially used ryoncil vials according institutional guidelines disposal biohazard materials . save thawed ryoncil vials future .",
    "adverseReactions": "ryoncil patients known hypersensitivity dimethyl sulfoxide ( dmso ) porcine bovine proteins .",
    "indications_original": "RYONCIL is indicated for the treatment of steroid refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months of age and older.",
    "contraindications_original": "For intravenous use only.",
    "warningsAndPrecautions_original": "RYONCIL is supplied as a sterile, cryopreserved cell suspension of ex-vivo culture-expanded allogeneic bone marrow-derived mesenchymal stromal cells (MSC) in vials.\n                  RYONCIL is provided as a customized kit to meet dosing requirements for a single dose for each patient [see Dosage and Administration (2.1)], with each kit containing:\n                  \n                     Cartons containing sufficient RYONCIL for one infusion based on the patient weight (see Table 5)\n                     Sufficient alcohol wipes for preparation of the RYONCIL infusions.\n                  \n                  Kit sizes and National Drug Codes (NDC) are provided in Table 5.\n                  \n                     Table 5: RYONCIL Kit Sizes\n                     \n                     \n                     \n                     \n                     \n                     \n                     \n                     \n                     \n                     \n                        \n                           Patient weight (kg)\n                           Kit contents (single infusion)\n                           Number of kits needed for:\n                        \n                        \n                           4-vial cartons\n                           1-vial cartons\n                           Total cartons\n                           Number of alcohol wipes\n                           NDC Number\n                           Initial course\n                           2nd course\n                           Relapse after CR\n                        \n                     \n                     \n                        \n                           <12.5\n                           0\n                           1\n                           1\n                           1\n                           73648-111-01\n                           8\n                           4\n                           8\n                        \n                        \n                           12.5-<25\n                           0\n                           2\n                           2\n                           2\n                           73648-112-02\n                        \n                        \n                           25-<37.5\n                           0\n                           3\n                           3\n                           3\n                           73648-113-03\n                        \n                        \n                           37.5-<50\n                           1\n                           0\n                           1\n                           4\n                           73648-114-01\n                        \n                        \n                           50-<62.5\n                           1\n                           1\n                           2\n                           5\n                           73648-115-02\n                        \n                        \n                           62.5-<75\n                           1\n                           2\n                           3\n                           6\n                           73648-116-03\n                        \n                        \n                           75-<87.5\n                           1\n                           3\n                           4\n                           7\n                           73648-117-04\n                        \n                        \n                           87.5-<100\n                           2\n                           0\n                           2\n                           8\n                           73648-118-02\n                        \n                     \n                  \n                  RYONCIL is shipped to the clinical facility in a liquid nitrogen dry shipper maintained at a temperature of \u2264 -135\u00b0C.\n                  \n                     Storage conditions: RYONCIL must remain frozen at \u2264 -135\u00b0C in liquid nitrogen vapor phase until thawed immediately prior to administration.\n                  \n                     Handling: Restrict preparation and administration of RYONCIL to a medical facility in which the medical personnel are trained in aseptic technique.\n                  \n                     Disposal: Dispose empty or partially used RYONCIL vials according to the institutional guidelines for disposal of biohazard materials.\n                  \n                     Do not save thawed RYONCIL vials for future use.",
    "adverseReactions_original": "Do not use RYONCIL in patients with known hypersensitivity to dimethyl sulfoxide (DMSO) or porcine and bovine proteins.",
    "drug": [
        {
            "name": "RYONCIL"
        }
    ]
}